Development Gene Silencing Genomics Pharma Companies 
pharmaphorum
OCTOBER 13, 2020
UK biotech e-therapeutics has a new CEO, with executive chairman and former Silence Therapeutics chief Ali Mortazavi chosen to spearhead the next stage in the company’s development into gene silencing and other areas. million fundraiser to keep the company running and was followed by another £11.6m
Drug Discovery World
OCTOBER 4, 2022
As it stands, there are currently 19 gene therapies approved for clinical use, alongside 18 RNA therapies and 59 non-genetically modified cell therapies, according to the Q2 report by the American Society of Cell & Gene Therapy. million by Horizon Europe which will go towards its goal of developing bioprocessing technologies. .
Expert insights. Personalized for you.
95 
Let's personalize your content